Published in Oncotarget on February 20, 2015
miR-196, an Emerging Cancer Biomarker for Digestive Tract Cancers. J Cancer (2016) 0.82
Regulatory Roles of Non-Coding RNAs in Colorectal Cancer. Int J Mol Sci (2015) 0.79
Adh enhances Actinobacillus pleuropneumoniae pathogenicity by binding to OR5M11 and activating p38 which induces apoptosis of PAMs and IL-8 release. Sci Rep (2016) 0.75
Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules. Oncotarget (2016) 0.75
Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b. Sci Rep (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
The hallmarks of cancer. Cell (2000) 113.05
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
The functions of animal microRNAs. Nature (2004) 64.85
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 23.59
MicroRNA-directed cleavage of HOXB8 mRNA. Science (2004) 18.33
Apoptosis by death factor. Cell (1997) 14.42
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA (2008) 12.26
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell (1991) 10.96
The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene (2007) 10.08
Lethal effect of the anti-Fas antibody in mice. Nature (1993) 9.20
MicroRNA expression and function in cancer. Trends Mol Med (2006) 7.02
Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer (2003) 6.92
CD95's deadly mission in the immune system. Nature (2000) 5.55
Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst (2005) 5.32
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol (2004) 5.12
MicroRNAs as oncogenes. Curr Opin Genet Dev (2005) 4.54
The Fas signaling pathway: more than a paradigm. Science (2002) 3.45
Modifiable risk factors for colon cancer. Gastroenterol Clin North Am (2002) 2.21
Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood (2009) 2.11
Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer (1994) 1.87
How tumours escape mass destruction. Oncogene (2008) 1.82
Evolution of microRNAs located within Hox gene clusters. J Exp Zool B Mol Dev Evol (2005) 1.77
MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res (2008) 1.69
Fas and Fas ligand: a death factor and its receptor. Adv Immunol (1994) 1.63
MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med (2011) 1.59
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun (2012) 1.49
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Haematologica (2010) 1.19
Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer. J Pathol (1998) 1.18
The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia. Leuk Res (2010) 1.14
Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia. Mol Cell Biochem (2010) 1.10
Countering the 'counterattack' hypothesis. Nat Med (2001) 1.01
Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia. Mol Cell Biochem (2010) 0.96
Fas ligand promotes tumor immune evasion of colon cancer in vivo. Cell Cycle (2006) 0.95
Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis. PLoS One (2013) 0.90
MicroRNA 375 regulates proliferation and migration of colon cancer cells by suppressing the CTGF-EGFR signaling pathway. Int J Cancer (2017) 0.75
MicroRNA 429 Regulates Mucin Gene Expression and Secretion in Murine Model of Colitis. J Crohns Colitis (2016) 0.75